Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

Presentation TCT 2022

TCT 60: The impact of implantation techniques in Absorb BVS and Xience EES on lesion oriented-outcomes at complete five-year follow-up – an AIDA trial QCA substudy

Presenter: Mick Renkens

September 17, 2022

Presentation TCT Abstracts Posters 2019

A 'Real-World' Multi-center Registry Evaluating Safety and Clinical Performance of Biodegradable Polymer Coated Ultra-Thin Everolimus-Eluting Stents: One-year Results From the PERFORM-EVER Registry

Presenter: Sridhar Kasturi

October 09, 2019

Presentation ARCH 2019

Update: Drug-Eluting Stents

Presenter: Jeffrey W. Moses

April 12, 2019

Presentation JIM 2019

TALENT: Thin strut sirolimus-eluting stent in all comers population vs Everolimus-eluting stent

Presenter: Giuseppe Tarantini

February 14, 2019

Presentation ESC 2018

ISAR-Absorb MI: A Prospective, Randomized Trial of BVS vs EES in Patients Undergoing Coronary Stenting for Myocardial Infarction

Presenter: Robert Byrne

August 29, 2018

Presentation

Impact of Post-Implant Asymmetry, Expansion, and Eccentricity of BVS and Metallic EES on Outcomes

Presenter: P. Suwannasom

June 03, 2016

Presentation

Safety and Efficacy of EES vs SES: 5-Year Results from SORT OUT IV

Presenter: Okkels Jensen

February 15, 2016

Presentation

EES vs CABG for Patients With Diabetes and Multivessel Disease

Presenter: Sripal Bangalore

July 30, 2015

Presentation

Final 5-Year Follow-up of an RCT of EES and PES for Coronary Revascularization in Daily Practice

Presenter: Pieter C. Smits

July 29, 2015

Presentation

RIBS IV: Drug-Coated Balloon (DCB) vs Everolimus-Eluting Stent (EES) in Patients With In-Stent Restenosis of DES

Presenter: Fernando Alfonso

June 30, 2015

Presentation

Stent Coverage and Neointimal Proliferation in BMS Postdilated With a Paclitaxel-Eluting Balloon vs EES

Presenter: T.C. Poerner

December 14, 2014

Presentation

Randomized Comparison of EES and SES in Patients With STEMI

Presenter: E. Di Lorenzo

August 22, 2014

Presentation

Randomized Comparison of PtCr-EES vs CoCr-ZES in All-Comers Receiving PCI

Presenter: K.W. Park

July 07, 2014

Presentation

Comparison of Biolimus A9-eluting (Nobori) and EES (Promus Element) in Long Coronary Lesions

Presenter: J.Y. Lee

May 29, 2014

Presentation

Third-Gen ZES and EES in All-Comers Patients Requiring PCI: DUTCH PEERS Noninferiority Trial

Presenter: Clemens von Birgelen

February 09, 2014

Presentation

A Randomized Comparison of drug-eluting balloon (DEB) vs. EES in pts with BMS In-stent Restenosis

Presenter: Fernando Alfonso

January 16, 2014

Presentation

A Clinical and Angiographic Study of the Xience V EES in the Treatment of Multivessel CAD

Presenter: Flavio Ribichini

September 23, 2013

Presentation

ZES vs. EES for Unprotected Left Main CAD

Presenter: Julinda Mehilli

August 22, 2013

Presentation

Biodegradable Polymer BES vs. Durable Polymer EES: A Randomized, Controlled, Non-inferiority Trial

Presenter: 221201|Masahiro Natsuaki

May 08, 2013

Presentation

Clinical Outcome Following Discontinuation of DAPT After 12 months in Real-World Patients Treated with Second-Generation ZES and EES

Presenter: K. Tandjung

April 26, 2013

Advertisement

TCT 60: The impact of implantation techniques in Absorb BVS and Xience EES on lesion oriented-outcomes at complete five-year follow-up – an AIDA trial QCA substudy

A 'Real-World' Multi-center Registry Evaluating Safety and Clinical Performance of Biodegradable Polymer Coated Ultra-Thin Everolimus-Eluting Stents: One-year Results From the PERFORM-EVER Registry

Update: Drug-Eluting Stents

TALENT: Thin strut sirolimus-eluting stent in all comers population vs Everolimus-eluting stent

ISAR-Absorb MI: A Prospective, Randomized Trial of BVS vs EES in Patients Undergoing Coronary Stenting for Myocardial Infarction

Impact of Post-Implant Asymmetry, Expansion, and Eccentricity of BVS and Metallic EES on Outcomes

Safety and Efficacy of EES vs SES: 5-Year Results from SORT OUT IV

EES vs CABG for Patients With Diabetes and Multivessel Disease

Final 5-Year Follow-up of an RCT of EES and PES for Coronary Revascularization in Daily Practice

RIBS IV: Drug-Coated Balloon (DCB) vs Everolimus-Eluting Stent (EES) in Patients With In-Stent Restenosis of DES

Stent Coverage and Neointimal Proliferation in BMS Postdilated With a Paclitaxel-Eluting Balloon vs EES

Randomized Comparison of EES and SES in Patients With STEMI

Randomized Comparison of PtCr-EES vs CoCr-ZES in All-Comers Receiving PCI

Comparison of Biolimus A9-eluting (Nobori) and EES (Promus Element) in Long Coronary Lesions

Third-Gen ZES and EES in All-Comers Patients Requiring PCI: DUTCH PEERS Noninferiority Trial

A Randomized Comparison of drug-eluting balloon (DEB) vs. EES in pts with BMS In-stent Restenosis

A Clinical and Angiographic Study of the Xience V EES in the Treatment of Multivessel CAD

ZES vs. EES for Unprotected Left Main CAD

Biodegradable Polymer BES vs. Durable Polymer EES: A Randomized, Controlled, Non-inferiority Trial

Clinical Outcome Following Discontinuation of DAPT After 12 months in Real-World Patients Treated with Second-Generation ZES and EES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content